PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • March 25th, 2025 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 25th, 2025 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 17th day of February 2025 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Stuart Hollenshead (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • February 21st, 2025 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 21st, 2025 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 17th day of February 2025 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Stuart Hollenshead (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 20th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 20th, 2024 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 1st day of January 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Jed Latkin (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 20th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 20th, 2024 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 15th day of April 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Lance Bisesar (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 9th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 9th, 2024 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 1st day of January 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Jed Latkin (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • December 1st, 2021 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 1st, 2021 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 19th day of November, 2021 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Samad Beeler (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • August 23rd, 2021 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 23rd, 2021 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”), is made effective as of the 10th day of August, 2021 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Kamal Obbad (hereinafter called the “Optionee”):